[144] Procter & Gamble Company SEC Filing

Rhea-AI Filing Summary

Form 144 notice from an insider at The Procter & Gamble Company (PG) reports a proposed sale of 11,578 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $1,793,490.09 and approximately 2,342,371,488 shares outstanding. The securities were acquired on 08/18/2025 as a Performance Stock Program Award and payment was recorded on the same date. The filer states there have been no sales by the person in the past three months and affirms no undisclosed material adverse information is known. This filing is a routine Rule 144 notice indicating the intention to sell company shares by an insider and does not include broader financial results or operational details.

Positive

• Clear disclosure of broker, sale date (08/19/2025), number of shares (11,578) and aggregate value ($1,793,490.09)
• Acquisition source disclosed as a Performance Stock Program Award from The Procter & Gamble Company, with acquisition and payment dated 08/18/2025

Negative

• None.

Insights

Financial Analyst

Routine insider sale notice; small relative size and no recent prior sales noted.

The Form 144 documents a proposed sale of 11,578 shares valued at $1.79 million. Versus ~2.34 billion shares outstanding, this volume is immaterial to share count and liquidity. Acquisition via a Performance Stock Program and same-day payment indicate planned disposition of awarded shares rather than market-moving divestiture. No past three-month sales reduces immediate signaling of an ongoing selling pattern.

Corporate Governance Expert

Compliance filing consistent with Rule 144; includes insider representation about material information.

The notice follows Rule 144 disclosure requirements, naming broker, sale date (08/19/2025), and acquisition details. The signer also affirms lack of non-public adverse information and references trading-plan language, though no plan adoption date is provided. This is procedural and does not by itself indicate governance concerns.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 38th Floor New York NY 10004	11578	1793490.09	2342371488	08/19/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/18/2025	Performance Stock Program Award	The Procter & Gamble Company			21372	08/18/2025	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for PG report?

The Form 144 reports a proposed sale of 11,578 shares of PG common stock valued at $1,793,490.09, to be sold on 08/19/2025 via Morgan Stanley Smith Barney LLC.

When and how were the shares being sold acquired?

The shares were acquired on 08/18/2025 as part of a Performance Stock Program Award from The Procter & Gamble Company, with payment recorded on the same date.

Does the filing show any other sales by the insider in the past three months?

No. The filing states "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.

Which broker and exchange are involved in the proposed sale?

The broker is Morgan Stanley Smith Barney LLC Executive Financial Services and the proposed sale is listed on the NYSE.

Does the filer assert knowledge of any undisclosed material information?

Yes. By signing, the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.